Developed by researchers at Rigshopitalet University Hospital (Rigshopitalet; Copenhagen, Denmark), the Neohelp pouch is made of dual-layer polyethylene with an adjustable hood and center fastening. The intuitive, easy to use pouch is fully transparent for monitoring of the baby’s skin color, movements, and overall well-being. The pouch is suitable for use in any setting where birth may take place, including delivery rooms, operating rooms, intensive care units (ICUs), emergency room, at home, or in an ambulance during transportation.

 

The first few minutes after birth are crucial; without proper protection, life-threatening hypothermia may develop, with the baby’s body temperature dropping by at least 2–4 °C during the first 10–20 minutes of life; and for every 1°C fall in temperature, the risk of mortality increases by 28%. Premature babies are more susceptible to hypothermia, and 56% of those weighing less than 750 grams have significant hypothermia upon admission to the neonatal ICY (nICU). The Neohelp pouch is a product of Vygon (Ecouen; France), and is available in three sizes that can be further adjusted for a snug fit. It is available in packs of ten.

 

“The product was developed in response to an unmet medical need for prevention of life threatening hypothermia in our most vulnerable patients – the sick, newborn and preterm infant,” said Morten Breindahl, MD, head of the Rigshopitalet neonatal and pediatric transport service, who co-developed the device. “With its double layer of plastic, Neohelp creates a protective microclimate and acts as an effective barrier against heat loss. At the same time, Neohelp is designed to improve observation, stabilization, handling, and resuscitation of the infant during the first vital minutes of life without the infant being exposed to a cold environment.”

 

“Vygon Group is committed to driving innovation by bringing the next generation of medical products to the market. This product launch fits perfectly with our philosophy, as the device was designed by health care professionals,” said Stéphane Regnault, chairman of the Vygon management board. “We are pleased to support the National University Hospital in Denmark in the development and launch of Neohelp. It is a simple, effective and low-risk method of combating hypothermia in newborns that complements existing preventive measures.”

 

Hypothermia is one of the main risk factors for morbidity and mortality in the newborn population and can occur in all climates, regardless of weight and gestational age. Multiple factors may cause the infant’s body temperature to fall at birth, such as evaporation of amniotic fluid, drafts, or simply contact with a cold surface. The urgent imperative to warm up consumes all available energy resources of the newborn in just a few moments, sometimes with serious long-term consequences, particularly in premature babies.